Apo-Efavirenz-Emtricitabine-Tenofovir 200 mg (Emtricitabine TABLET) 200 MG

APO-Efavirenz-Emtricitabine-Tenofovir 200 MG tablets combine three active ingredients for HIV treatment. This oral medication is designed to help manage HIV infection as part of a comprehensive treatment plan.

Strength

200 MG

Pack Size

30/90

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-Efavirenz-Emtricitabine-Tenofovir 200 MG tablets are used in the treatment of HIV infection. This combination medication works by reducing the amount of HIV in the body, helping to control the infection. It is typically prescribed as part of a broader antiretroviral therapy regimen to manage HIV and improve quality of life.

Side Effects

Common effects of APO-Efavirenz-Emtricitabine-Tenofovir 200 MG tablets may include dizziness, nausea, and fatigue. Some individuals may experience changes in mood or sleep patterns. These effects vary and should be discussed with a healthcare provider.

Precautions & Warnings

APO-Efavirenz-Emtricitabine-Tenofovir 200 MG tablets should be handled with care. Store at room temperature away from moisture and heat. Follow the prescribed dosage and administration instructions provided by your healthcare provider to ensure safe and effective use.

Avoid Interactions

APO-Efavirenz-Emtricitabine-Tenofovir 200 MG tablets may interact with other medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.

Frequently Asked Questions

APO-Efavirenz-Emtricitabine-Tenofovir 200 MG tablets are used to treat HIV infection as part of a comprehensive antiretroviral therapy regimen.

Store APO-Efavirenz-Emtricitabine-Tenofovir 200 MG tablets at room temperature away from moisture and heat.

Common effects may include dizziness, nausea, and fatigue. Some individuals may experience changes in mood or sleep patterns.

APO-Efavirenz-Emtricitabine-Tenofovir 200 MG tablets may interact with other medications. Consult your healthcare provider before combining with other treatments.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.